Nano-X Imaging’s (NNOX) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Nano-X Imaging (NASDAQ:NNOX) in a research report sent to investors on Monday,Benzinga reports. They currently have a $15.00 price objective on the stock.

Separately, Cantor Fitzgerald increased their price objective on Nano-X Imaging from $11.00 to $12.00 and gave the stock an “overweight” rating in a report on Friday, December 6th.

Nano-X Imaging Trading Down 4.6 %

Shares of NNOX opened at $4.99 on Monday. The stock has a 50 day simple moving average of $6.55 and a 200-day simple moving average of $6.64. The stock has a market cap of $288.32 million, a PE ratio of -5.87 and a beta of 1.99. Nano-X Imaging has a 1 year low of $4.61 and a 1 year high of $11.39.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings results on Monday, March 31st. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. On average, sell-side analysts forecast that Nano-X Imaging will post -0.92 EPS for the current fiscal year.

Hedge Funds Weigh In On Nano-X Imaging

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. US Bancorp DE lifted its position in shares of Nano-X Imaging by 388.7% in the fourth quarter. US Bancorp DE now owns 3,470 shares of the company’s stock valued at $25,000 after buying an additional 2,760 shares during the last quarter. Quadrant Capital Group LLC lifted its holdings in Nano-X Imaging by 464.9% during the 4th quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock valued at $51,000 after purchasing an additional 5,774 shares during the last quarter. Quantum Private Wealth LLC bought a new position in Nano-X Imaging during the fourth quarter worth $72,000. Signaturefd LLC increased its holdings in shares of Nano-X Imaging by 164.6% in the fourth quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock valued at $75,000 after purchasing an additional 6,464 shares during the last quarter. Finally, PharVision Advisers LLC bought a new position in shares of Nano-X Imaging in the fourth quarter valued at about $80,000. Institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.